WuXi AppTec
A Platform that Transforms Pharma Outlook

Think of a world where there is a cure for every ailment, not just as a far-fetched dream but by the implications of technological innovations that go far beyond the conventional approach. And such is the feat globally acclaimed companies are edging to achieve in the healthcare and pharmaceutical industry.

COVID-19, too, was a stimulus to new innovations; it acted as a catalyst for the long-brewing transformation in the industries, making them more flexible and adaptable. However, businesses and companies that are relying on technology to establish a digitally governed medical environment, from the entire supply chain to creating medications and performing clinical studies, are bound to be grid-locked by the conventional modalities of the technological world, lest they proceed with caution and attention to detail or risk high attrition rate in the industries. And to address the need of the hour, WuXiAppTec has set out to alleviate an array of concerns that the companies may encounter in this turbulent pharma.

WuXiAppTec provides a comprehensive range of skills and services to companies and businesses, allowing them to develop novel medications at every stage of the R&D process. This integrated open-access platform aids in the reduction of R&D hurdles and the rapid delivery of novel medications to patients around the world.

With the WuXiAppTec’s integrated, end-to-end services such as chemistry drug CRDMO (Contract Research, Development, and Manufacturing Organization), biology discovery, preclinical testing, clinical research services, cell, and gene therapies CTDMO (Contract Testing, Development, and Manufacturing Organization), WuXiAppTec is bridging the gap in the market to improve the productivity of developing healthcare products through cost-effective and efficient solutions.

Though there are precarious prospects in the healthcare business, especially in drug developments, clinical trials, and other such, a propitious approach towards addressing the challenges facilitates not only solutions, but also a significant breakthrough. With such pulsating progress, WuXiAppTec has been leading the markets in providing a comprehensive range of R&D and manufacturing services to the global pharmaceutical and healthcare industries, allowing them to advance discoveries and give patients revolutionary treatments.

WuXiAppTec has transformed services into solutions that alleviate industry bottlenecks, accelerate time to market, and support commercial programs around the world through continued internal reinvestment in facilities, technology, and talent, as well as over three decades of biopharmaceutical testing expertise. The company’s underline feature is the discovery chemistry platform which provides synthetic and medicinal chemistry solutions for creating, identifying, and supporting the identification of preclinical candidates for worldwide pharma and biotech companies (PCCs).

WuXi AppTec’s discovery chemistry platform provides synthetic and medicinal chemistry solutions for creating, identifying, and supporting the identification of preclinical candidates for worldwide pharma and biotech companies

The company’s unique Chem-on- Demand service provides academic work on novel biology targets with synthetic chemistry, chemical design, and project management. WuXiAppTech has also transformed stand-alone services into a clinical manufacturing solution that allows for a shorter time to first in human trials by integrating development, testing, and production.

Though a broad spectrum of biological and clinical services and solutions are available in the market to aid initiatives of the businesses, WuXiAppTec is a class by itself in assisting clients in managing project deadlines and compound flow through various stages of discovery in order to complete projects in a timely manner.